IC51 Japanese encephalitis vaccine (Q37519659)

20 August 2017

1 reference

title

IC51 Japanese encephalitis vaccine (English)

1 reference

Japanese encephalitis virus

20 August 2017

main subject

0 references

vaccine

0 references

Japanese encephalitis

1 reference

1 reference

Herwig Kollaritsch

0 references

Maria Paulke-Korinek

1 reference

20 August 2017

Katrin Dubischar-Kastner

series ordinal

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Expert Opinion on Biological Therapy

20 August 2017

published in

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

921-931

1 reference

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Complete nucleotide sequence of the Japanese encephalitis virus genome RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Japanese encephalitis for a reference to international travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Factors influencing the abundance of Japanese encephalitis vectors in ricefields in India--I. Abiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Current use and development of vaccines for Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Control of Japanese encephalitis--within our grasp?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Japanese encephalitis: a Chinese solution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

21 January 2018

Pathogenic flaviviruses.

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Japanese encephalitis vaccine in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Duration of neutralizing antibody titer after Japanese encephalitis vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Short‐Term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA14–14–2): Results of a Randomized Trial with 26,239 Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

New vaccines for Japanese encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Protection against Japanese encephalitis by inactivated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Allergic reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Systemic allergic reactions to Japanese encephalitis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Side-effects with Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Vaccines in travel health: from risk assessment to priorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903042282

10.1517/14712590903042282

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference